Safety and efficacy of a novel transbronchial radiofrequency ablation system for lung tumours: One year follow‐up from the first multi‐centre large‐scale clinical trial (BRONC‐RFII)

• Published in: Respirology (Carlton, Vic.) Vol. 30; no. 1; pp. 51 - 61
• Main Authors: Zhong, Changhao, Chen, Enguo, Su, Zhuquan, Chen, Difei, Wang, Feng, Wang, Xiaoping, Liu, Guangnan, Zhang, Xiaoju, Luo, Fengming, Zhang, Nan, Wang, Hongwu, Jin, Longyu, Long, Fa, Liu, Chunfang, Wu, Shiman, Geng, Qing, Wang, Xiang, Tang, Chunli, Chen, Ruchong, Herth, Felix J. F., Sun, Jiayuan, Li, Shiyue
• Format: Journal Article
• Language: English
• Published: Chichester, UK John Wiley & Sons, Ltd 01.01.2025; Wiley Subscription Services, Inc
• Subjects: Ablation; Adult; Aged; Aged, 80 and over; bronchoscopy; Bronchoscopy - instrumentation; Bronchoscopy - methods; Catheter Ablation - adverse effects; Catheter Ablation - instrumentation; Catheter Ablation - methods; Clinical trials; Female; Follow-Up Studies; ground‐glass nodule; Humans; Lung cancer; Lung Neoplasms - mortality; Lung Neoplasms - pathology; Lung Neoplasms - surgery; lung tumour; Male; Middle Aged; Nodules; Original; ORIGINAL ARTICLE; Patients; Pleural effusion; Pneumothorax; Radiofrequency ablation; Radiofrequency Ablation - adverse effects; Radiofrequency Ablation - instrumentation; Radiofrequency Ablation - methods; Survival; Survival Rate; Treatment Outcome; Tumors; Young Adult; lung tumour; radiofrequency ablation; ground‐glass nodule; bronchoscopy

Background and Objective Radiofrequency ablation (RFA) is an emerging treatment of lung cancer, yet it is accompanied by certain safety concerns and operational limitations. This first multi‐centre, large‐scale clinical trial aimed to investigate the technical performance, efficacy and safety of an...